Shionogi Of Japan Wins U.S. Patent Fight To Protect Its Crestor Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi won a victory in a U.S. court that upheld the firm's patent for Crestor (rosuvastatin), a leading anti-cholesterol drug